Rocket Doctor AI hires B2i Digital for investor marketing push

Rocket Doctor AI has signed a three-month digital advisory agreement with B2i Digital, pending Canadian Securities Exchange approval, to expand investor outreach across social, email, and paid media. The deal is designed to boost the healthcare AI company’s visibility in the U.S. market and reach B2i Digital’s network of more than 1.7 million market participants.

Why it matters: - Rocket Doctor AI is using a dedicated investor-marketing campaign to widen awareness of its physician-built, AI-powered healthcare tools. - The agreement gives the company access to B2i Digital’s network of more than 1.7 million retail and institutional market participants. - The push could help Rocket Doctor AI reach U.S. investors and potential conference audiences as it tries to grow beyond Canada.

What happened: - Rocket Doctor AI Inc. entered into a digital advisory agreement with B2i Digital, Inc. for investor-focused marketing services. - The agreement is subject to approval by the Canadian Securities Exchange. - The campaign is expected to begin on or about Aug. 5, 2026, and run for an initial three-month term. - Rocket Doctor AI’s CEO, Dr. Essam Hamza, said the collaboration is part of a strategic initiative to broaden the company’s presence across the U.S., including New York.

The details: - B2i Digital will build and maintain a featured company profile on b2idigital.com. - B2i Digital will create and manage paid digital ad campaigns, investor-focused content and creative materials, and email marketing to the investing community. - The firm will distribute content across LinkedIn, Facebook, X, Instagram, Threads, Stocktwits, YouTube, Reddit, TikTok, Pinterest and Bluesky. - The services also include Webull Corporate Communications and introductions to relevant investor conferences and speaking opportunities. - Rocket Doctor AI will pay B2i Digital a cash fee of $21,375 USD at the start of the agreement. - During the first month, Rocket Doctor AI can extend the term to six months for an additional $14,625 USD or to 12 months for an additional $32,625 USD. - The agreement will not renew automatically unless both sides confirm renewal in writing before the term ends. - The compensation does not include options to buy Rocket Doctor AI securities. - B2i Digital is an arm’s-length service provider retained only for digital marketing advisory services.

Between the lines: - B2i Digital said it selects only a small group of companies for its Featured Company program. - David Shapiro, B2i Digital’s CEO, said Rocket Doctor AI addresses a fundamental problem in the U.S. healthcare system. - The arrangement looks designed to pair Rocket Doctor AI’s healthcare message with B2i Digital’s broad retail-investor distribution channels.

What's next: - Promotional activity is expected to run for about three months unless Rocket Doctor AI exercises the option to extend the agreement. - Any longer-term campaign depends on the company choosing to convert the contract during the first month and on continued written agreement from both parties. - The launch also remains contingent on exchange approval.

The bottom line: - Rocket Doctor AI is buying a targeted capital-markets marketing lift to raise visibility with investors as it pushes its AI-enabled healthcare platform into the U.S. market.